The 2025 Global Burden of Disease analysis, published in The Lancet and drawing from 2,230 studies across 133 countries, reveals chronic kidney disease (CKD) cases doubling from 378 million in 1990 to 788 million in 2023, now claiming 1.5 million lives annually and ranking in the top 10 causes of death. This peer-reviewed GBD effort, unlike preprints, uses standardized modeling but acknowledges limitations in data-scarce regions like sub-Saharan Africa where underdiagnosis inflates uncertainty. While the source emphasizes early-stage prevalence (about 14% of adults) and links to cardiovascular deaths (12% globally), it underplays how CKD amplifies healthcare system strain amid aging populations and the diabetes-obesity syndemic—patterns seen in prior GBD iterations and a 2023 WHO noncommunicable disease report. Missed connections include uneven dialysis access driving higher disability-adjusted life years in low-income areas, where SGLT2 inhibitors could intervene cost-effectively yet remain inaccessible. Synthesizing with a 2024 NEJM review on CKD progression, this signals systemic failures: policymakers must integrate routine eGFR screening into primary care to avert dialysis surges, or risk overwhelming systems as cardiovascular comorbidities compound. The analysis warns of 6%+ age-adjusted death increases since 1993, underscoring that lifestyle and glycemic control alone won't suffice without equity-focused policies.